Analysts Set Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Target Price at $68.27
Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have earned an average recommendation of “Moderate Buy” from the twelve research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average […]
Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have earned an average recommendation of “Moderate Buy” from the twelve research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average […]
